Prevalence and Characteristics of Avoidant/Restrictive Food Intake Disorder in Pediatric Neurogastroenterology Patients.


Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
01 05 2022
Historique:
pubmed: 16 12 2021
medline: 20 5 2022
entrez: 15 12 2021
Statut: ppublish

Résumé

Recent reports document avoidant/restrictive food intake disorder (ARFID) symptoms among 13-40% of adults presenting to neurogastroenterology clinics, but ARFID in pediatrics is understudied. We conducted a retrospective review of charts from 129 consecutive referrals (ages 6-18 years; 57% female) for pediatric neurogastroenterology examination, from January 2016 through December 2018. Eleven cases (8%) met the full criteria for ARFID by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition and 19 cases (15%) had clinically significant avoidant/ restrictive eating behaviors with insufficient information for a definitive ARFID diagnosis. Of patients with ARFID symptoms (n = 30), 20 (67%) cited fear of gastrointestinal symptoms as motivation for their avoidant/ restrictive eating. Compared to patients without ARFID symptoms, patients with ARFID symptoms were older (P  < .001), more likely to be female (51% vs 79%, P  = 0.014), and more frequently presented with eating/weight-related complaints (15% vs 33%, P  = 0.026). This pilot retrospective study showed ARFID symptoms present in 23% of pediatric neurogastroenterology patients; further research is needed to understand risk and maintenance factors of ARFID in the neurogastroenterology setting.

Identifiants

pubmed: 34908014
doi: 10.1097/MPG.0000000000003369
pii: 00005176-202205000-00008
pmc: PMC10126824
mid: NIHMS1881829
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

588-592

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK120945
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK131334
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Déclaration de conflit d'intérêts

Conflicts of Interest: B.K. has received research support from AstraZeneca, Takeda, Gelesis, Medtronic, Genzyme and has served as a consultant to Shire, Takeda, and Ironwood. K.S. has received research support from Takeda, Ironwood, and Urovant, has been a speaker for Shire, and a consultant for Arena, Boston Pharmaceuticals, and Gelesis. J.J.T. receives royalties from Cambridge University Press for the sale of her books on avoidant/restrictive food intake disorder. All other authors have no personal or financial conflicts to declare.

Références

DrossmanD, Chang L, Chey WD (Eds):et al. ROME IV: Functional Gastrointestinal Disorders – Disorders of Gut–Brain Interaction. 4th ed. Raleigh, NC: Rome Foundation; 2016. No. 2.
Reed-Knight B, Squires M, Chitkara DK, et al. Adolescents with irritable bowel syndrome report increased eating-associated symptoms, changes in dietary composition, and altered eating behaviors: a pilot comparison study to healthy adolescents. Neurogastroenterol Motil 2016; 28:1915–1920.
Burton Murray H, Kuo B, Eddy KT, et al. Disorders of gut-brain interaction common among outpatients with eating disorders including avoidant/restrictive food intake disorder. Int J Eat Disord 2021; 54:952–958.
Murray HB, Jehangir A, Silvernale CJ, et al. Avoidant/restrictive food intake disorder symptoms are frequent in patients presenting for symptoms of gastroparesis. Neurogastroenterol Motil 2020; 32:e13931.
Harer K, Baker J, Reister N, et al. Avoidant/restrictive food intake disorder in the adult gastroenterology population: an under-recognized diagnosis? Philadelphia, PA: American College of Gastroenterology Annual Meeting; 2018.
Murray HB, Bailey AP, Keshishian AC, et al. Prevalence and characteristics of avoidant/restrictive food intake disorder in adult neurogastroenterology patients. Clin Gastroenterol Hepatol 2019; 18: 1995.e1–2002.e1.
APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed.Arlington, VA: American Psychiatric Publishing; 2013.
Thomas JJ, Lawson EA, Micali N, et al. Avoidant/restrictive food intake disorder: a three-dimensional model of neurobiology with implications for etiology and treatment. Curr Psychiatry Rep 2017; 19:54.
Vriesman MH, Koppen IJN, Camilleri M, et al. Management of functional constipation in children and adults. Nat Rev Gastroenterol Hepatol 2020; 17:21–39.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159–174.
Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 2015; 42:418–427.
Brown SC, Whelan K, Gearry RB, et al. Low FODMAP diet in children and adolescents with functional bowel disorder: a clinical case note review. JGH Open 2020; 4:153–159.
Dionne J, Ford AC, Yuan Y, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol 2018; 113:1290–1300.
Thomas JJ, Eddy K. Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Children, Adolescents, and Adults Cambridge. UK: Cambridge University Press; 2019.
Thomas JJ, Becker KR, Kuhnle MC, et al. Cognitive-behavioral therapy for avoidant/restrictive food intake disorder: feasibility, acceptability, and proof-of-concept for children and adolescents. Int J Eat Disord 2020; 53:1636–1646.
Whelan K, Martin L, Staudacher H, et al. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 2018; 31:239–255.
Chey WD. Elimination diets for irritable bowel syndrome: approaching the end of the beginning. Am J Gastroenterol 2019; 114:201–203.
Eddy KT, Thomas JJ, Hastings E, et al. Prevalence of DSM-5 avoidant/restrictive food intake disorder in a pediatric gastroenterology healthcare network. Int J Eat Disord 2015; 48:464–470.
Harshman SG, Jo JH, Kuhnle MC, et al. A moving target: how we define avoidant/restrictive food intake disorder can double its prevalence. J Clin Psychiatry 2021; 82:20m13831.
Murray HB, Dreier MJ, Zickgraf HF, et al. Validation the nine item ARFID Screen (NIAS) subscales for distinguishing ARFID presentations and screening for ARFID. Int J Eat Disord 2021; 54:1782–1792.

Auteurs

Helen Burton Murray (HB)

Center for Neurointestinal Health, Massachusetts General Hospital.
Harvard Medical School.
Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, MA.

Fatima U Rao (FU)

Center for Neurointestinal Health, Massachusetts General Hospital.

Corey Baker (C)

Center for Neurointestinal Health, Massachusetts General Hospital.
Center for Neurogastroenterology and Motility Disorders, Connecticut Children's Medical Center, Hartford, CT.

Casey J Silvernale (CJ)

Center for Neurointestinal Health, Massachusetts General Hospital.

Kyle Staller (K)

Center for Neurointestinal Health, Massachusetts General Hospital.
Harvard Medical School.

Stephanie G Harshman (SG)

Harvard Medical School.
Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, MA.
Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA.

Jennifer J Thomas (JJ)

Harvard Medical School.
Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, MA.

Braden Kuo (B)

Center for Neurointestinal Health, Massachusetts General Hospital.
Harvard Medical School.

Claire Zar-Kessler (C)

Center for Neurointestinal Health, Massachusetts General Hospital.
Harvard Medical School.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH